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Abstract 
Background 
Drug administration errors have seen a marked rise in the medical fraternity. In 
anaesthesia these are expected to be higher as for any anaesthetic given, multiple 
drugs are administered. Although many risk factors have been identified as causes 
of medication errors, in anaesthesia in particular, syringe labelling has been 
identified as an easily preventable source of medication error.  
Methodology 
The aim of this study was to audit the syringe labelling practices of anaesthetists in 
four academic hospitals affiliated to the University of the Witwatersrand. The 
research design used to conduct the study was a prospective, contextual and 
descriptive one. The study population was all syringes prepared for anaesthesia 
during the course of the data collection days at the four academic hospitals. A 
consecutive convenience sampling method was used to collect the data 
Results 
A total of 279 syringes were included in the study. Of the 279 syringes, 242 (87%) 
were labelled. Six (2%) of the 242 labels were colour coded. A total of 37 (13%) 
syringes had no labelling at all. 
All labelled syringes had the name of the medication present, either in full or 
abbreviated. Two hundred and nine (86%) of the labelled syringes had the dose 
and/or concentration of the medication. Fifteen (6%) of syringes had date, 6(2%) 
had time. A total of six (2%) syringes had a signature of the person who prepared 
the drug and one (0.4%) had a signature of the person that checked the drug. The 
majority 193 (69%) of syringes had only two out of the six required labelling items. 
Conclusion 
This study revealed that syringe labelling practices of anaesthetists in the four 
academic hospitals associated with Wits did not meet the recommended 
standards. It is recommended that a standard operating procedure for syringe 
labelling be introduced as studies have shown that syringe labelling is an easy 
way of preventing and/or reducing medication error. 
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Chapter 1: Overview of the study 
1.1 Introduction 
This study is of an audit of syringe labelling practices of anaesthetists in four 
academic hospitals affiliated to the University of the Witwatersrand (Wits). In this 
chapter the study is introduced under the headings: background, problem statement, 
aim, objective, research assumptions, demarcation of the study field, ethical 
considerations, research methodology, significance of study and study outline. 
1.2 Background 
An increase in errors in the medical profession has been seen recently so much so 
that the term “error pandemic” is being used in some medical publications. Kohn et al 
(1) stated that “it is human to err”, however, in the medical profession these errors 
may lead to severe disabilities and fatalities. In various studies the incidence of these 
errors have been very high and the resultant fatalities have been extrapolated to 
surpass those resulting from vehicle accidents, breast cancer and AIDS in the 
USA(1, 2).  
Medication errors are a hindrance to patient safety initiatives. They, however, are 
often preventable, especially if medical practitioners adhere to prescribed 
protocols(3). Patient safety is defined by the World Health Organisation (WHO) as 
ensuring that patients are protected against preventable harm (4). Llewellyn et al (5) 
have suggested that patient safety be included in the curriculum of medical students 
and in continued training of doctors as it is invaluable in the health care profession. 
Orser et al (6)refers to anaesthesiology as the “ODAM” profession as unlike other 
practitioners, anaesthetists order, dispense, administer and monitor high risk drugs, 
all this while performing other duties in the operating theatre. This is why anaesthetic 
practice is susceptible to medication errors, the true incidence of which is likely to be 
higher than the literature suggests, as the statistics are dependent on self 
reporting.(6) 
Another reason for the underestimation of the impact of errors is that mortality is 
rarely reported as a result of medication errors. This is because often the outcome of 
anaesthesia and surgery can be attributed to multiple factors and there may be 
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under reporting of drug errors, especially when the anaesthetist remains ignorant of 
the error. (3) 
Syringe labelling has been identified as a significant and easily preventable source of 
medication errors. It is alarming, however, that although simple studies revealed that 
although simple, the compliance to consistent syringe labelling was very poor, 
ranging from 37 to 70% .(7, 8).The Helsinki Declaration on Patient Safety in 
Anaesthesia (7) states that all institutions administering anaesthesia should include 
syringe labelling in their list of protocols. A South African study conducted in an 
academic hospital in the Free State concluded that only 62% of the anaesthetists 
were aware of the existence of standardised colour coded syringe labels and of 
these anaesthetists, only 19% reported using them.(8) 
The poor compliance with syringe labelling protocols and ignorance of their 
existence is disquieting as there are a number of guidelines and standards that have 
been published regarding syringe labels (3, 9-12). These include the International 
Standard Organisation (ISO)(13), from which the majority of the standards have 
been adopted. 
The outcome of medication errors in anaesthesia can vary from no adverse event to 
fatalities, depending on the drugs administered. Medication errors in anaesthesia 
can lead to adverse events. The most frequently reported were awareness during 
anaesthesia and prolonged action of muscle relaxants, leading to unplanned post-
operative ventilation and prolonged unconsciousness (14). In other instances 
disability and death may result and these lead to legal action being taken against the 
practitioner or the health care facility. The American Society of Anesthesiologists 
(ASA) Closed Claims Project found that as many as 4% of the malpractice cases in 
anaesthesia were due to errors of drug administration. These were largely related to 
administration of incorrect doses or incorrect drugs. (15) 
The consequences of these errors may extend to judgments being passed in the 
courts of law. Merry et al (16) state that there is a move towards a just culture 
system, where there is a tendency to blame the system as opposed to the individual. 
This is a reasonable approach where a practitioner consistently adheres to safety 
and prescribed guidelines. “On the other hand, if a practitioner chooses to ignore 
widely accepted safety practices (such as labelling syringes), then blame may be 
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appropriate. In a just culture, the question becomes one of differentiating 
blameworthy behaviour from blameless behaviour.” (16) This may lead to a 
judgement such as manslaughter being imposed in a case where such an error has 
resulted in a loss of life. In the case where the error has resulted in severe disability, 
fines may be awarded. Twenty four million pounds were awarded to an 11 year old 
girl who was left with a severe disability after the contents of an unlabelled syringe 
(containing tissue glue), mistaken for contrast, was injected intra-arteriallypost an 
aneurysm repair(17). 
1.3 Problem statement 
Studies done internationally and nationally have revealed that erroneous drug 
administration was a frequent occurrence in anaesthetic practice (8, 11, 14, 18-22). 
This is not unexpected as the average anaesthetist administers at least a quarter of 
a million drugs in the course of their professional career (22). An important cause of 
medication error that has been highlighted in the literature is that of incorrect syringe 
labelling (3, 11, 16, 18, 20, 22, 23). 
In South Africa, the South African National Standards (SANS 26825:2009) (24) 
based on the ISO standard of 2008(13), recommends the use of standard colour 
coded labels to mark syringes used forthe administration of anaesthetic drugs. This 
standard also includes general properties, such as size, adhesive properties etc, 
which a syringe label should meet. However, it is important to note that additional 
information such as the date, the time and the signature of the healthcare worker 
who prepared the syringe should also appear on the label. 
Currently, in the operating theatres of the hospitals affiliated to the Department of 
Anaesthesiology at Wits, various medications such as emergency, induction and 
analgesic agents and antibiotics, are prepared in advance by a healthcare worker. 
The researcher's perception is that syringes are not marked in the recommended 
manner. A concern is that the person administering the prepared medication is often 
not the person who prepared it. Jansen (25) stated in her thesis that “No medical 
practitioner (or any other health worker) may administer medication without checking 
it properly” (translation from Afrikaans). 
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The syringe labelling practices of anaesthetists working in four academic hospitals 
affiliated to Wits was unknown.  
1.4 Aim 
The aim of this study was to audit the syringe labelling practices of anaesthetists in 
four academic hospitals affiliated to Wits. 
1.5 Objectives 
The objectives of this study were to: 
 describe the current method of labelling syringes 
 describe the information recorded on the syringes  
 document the number of items written on each syringe label. 
1.6 Research assumptions 
The following definitions were used in the study. 
Syringe: refers to a syringe on an anaesthetic work surface, filled with medication, 
for use by the anaesthetist and does not include those that were empty or labelled 
“flush”. 
Predetermined standard: refers to the standard against which the current syringe 
labelling practices was compared. This was drawn up following an extensive 
literature review and included the following: name of medication, dose/concentration 
of medication, date and time medication was prepared, signature of person 
preparing medication and signature of person checking medication. 
1.7 Demarcation of study field 
The research was done in the operating theatres of Chris Hani Baragwaneth 
Academic Hospital (CHBAH), Charlotte Maxeke Johannesburg Academic Hospital 
(CMJAH), Helen Joseph Hospital (HJH) and RahimaMoosa Mother and Child 
Hospital (RMMCH). All four of the above hospitals are affiliated to Wits. 
 CHBAH is a central hospital with 2888 beds and 25 theatres  
 CMJAH is a central hospital with 1200 beds and 23theatres  
 HJH is a regional hospital with 500 beds and 7 theatres  
 RMMCH is a regional 338 beds and 5 theatres  
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1.8 Ethical considerations 
Approval to conduct the study was obtained from the Postgraduate Committee of 
Wits (Appendix 1). The Human Research Ethics Committee (Medical) of Wits was 
approached for an ethical waiver (Appendix 2) as this was a study not involving 
human subjects. Approvals were received from the Medical Advisory Committee of 
CHBAH (Appendix 3) and the CEOs of CMAH, HJH and RMMCH (Appendix 4). 
1.9 Research methodology 
The research design was prospective, contextual and descriptive. The study 
population was all syringes prepared for anaesthesia during the data collection 
period at each of the four academic hospitals. A consecutive convenience sampling 
method was used to collect data. Data was collected on two consecutive days to 
ensure that the routine syringe labelling by anaesthetists was not influenced by the 
study. All the syringes on all the anaesthetic surfaces in all the functioning theatres in 
the four hospitals were evaluated on two consecutive days. Each theatre was only 
included once to ensure that syringes prepared by any one anaesthetist were not 
included more than once. All syringes on anaesthetic work surfaces containing 
solutions were included in the study and those that were empty and unlabelled or 
labelled “flush” were excluded. 
1.10 Significance of the study 
Studies done internationally and nationally have revealed that erroneous drug 
administration is a frequent occurrence in anaesthetic practice (11, 14, 16, 22, 26, 
27). This is not unexpected as the average anaesthetist administers at least a 
quarter of a million drugs in the course of their professional career (22). An important 
cause of medication error that has been highlighted in the literature is that of 
incorrect syringe labelling (9, 11, 18, 19, 26, 28). The anaesthetist is legally 
accountable for drug errors that occur (25). 
Should this audit reveal inadequate syringe labelling practices amongst 
anaesthetists in the study hospitals, this may lead to the standardisation of drug 
labelling and therefore safer patient care in the Department of Anaesthesiology at 
Wits. 
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1.11 Study outline 
The study contains the following chapters: 
Chapter 1 Overview of the study 
Chapter 2 Literature review 
Chapter 3 Research methodology 
Chapter 4 Results and discussion 
Chapter 5 Summary, limitations, recommendations and conclusion. 
 
1.12 Summary 
In this chapter a brief overview of the study was given. The following chapter 
contains the literature review. 
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Chapter 2: Literature review 
2.1 Introduction 
In this chapter, the literature related to this study is reviewed under the following 
headings: patient safety and medical errors, medication administration errors in 
anaesthesiology, drug error coding system, syringe labelling practices both 
international and local, guidelines for syringe labels, legal requirements, legal 
consequences and management of drug errors. 
2.2 Patient safety and medical errors 
WHO defines patient safety as, “the absence of preventable harm to a patient during 
the process of health care.” The discipline of patient safety is the coordinated effort 
to prevent harm, caused by the process of health care itself, from occurring in 
patients (4). 
The 2000 American Institute of Medicine‟s now famous report “To err is human, 
building a safer health system” (1) has given rise to the so called “patient safety 
movement” that has resulted in an increased awareness of patient safety and 
research to address the safety of health systems (29). 
Human beings, irrespective of their profession, unfortunately are prone to making 
errors. The medical profession as a whole, including the anaesthetic speciality 
provide no exception. This is especially true in recent decades, so much so that 
some medical publications have coined the term “error pandemic”. These errors, 
however, are preventable with the establishment of guidelines which, when 
consistently adhered to, will minimise both the number and amplitude of these errors. 
(1) 
High risk industries such as aviation and nuclear plants have a comparably better 
safety record than health care. There is a 1 in 100 000 chance of a traveller being 
harmed while in an aircraft. However there is a 1 in 300 chance of a patient being 
harmed when receiving health care. (4) 
Studies conducted in various institutions throughout the world have all reported an 
alarmingly high incidence of medical errors, a significant number of which have led to 
fatalities. In a study conducted in Colorado and Utah hospitals in the United States of 
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America (USA), the fatalities from preventable medical errors were so high that, once 
extrapolated, revealed this to be one of the leading causes of death in the USA, 
surpassing vehicle accidents, breast cancer and AIDS. (1) 
In monetary value, the total cost of medical errors in the USA was estimated to be 
between 17 to 29 billion US dollars. Half of these costs were medical costs as a 
result of prolonged hospitalisation. The rest of the cost was attributed to loss of 
income. It is however the patient‟s loss of trust and even fear of the healthcare 
facilities and the healthcare professional‟s loss of confidence in themselves that 
constitute the greatest loss. This human cost is often not emphasised as it is not 
easy to measure, yet its value undeniably high. (1, 2) 
In Seattle, during a procedure for a coil placement in a cerebral angiography to 
repair a brain aneurysm of a 69 year-old woman, clear chlorhexidine solution was 
injected into her arteries instead of contrast. This error occurred as both basins 
containing the two solutions were not labelled and the solutions looked the same. At 
the end of the procedure, contrast medium had to be injected into her artery for 
radiographic visualisation of the repair site. At this point chlorhexidine was drawn into 
the syringe; the patient received the antiseptic into her artery. This toxic substance 
resulted in multi-organ failure and both her legs being amputated before she 
eventually succumbed to the toxin. This tragic demise of a 69 year-old woman is a 
stark reminder of the horrors that can be prevented with a step as simple as the 
application of a label. Just as tragic is the emotional impact of such errors on the 
affected families: once the family found out that the error that resulted in their 
mother‟s death could have been avoided with a label, they pledged to get involved in 
promoting greater awareness of patient safety.(30, 31)Medical errors such as this 
case are preventable, especially if prescribed protocols, which are aimed at ensuring 
patient safety, are enforced (1). 
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Patient safety in anaesthesiology is emphasised in the Helsinki Declaration on 
Patient Safety in Anaesthesiology(7), which is expressed as a set of principal 
requirements that state that any institution administering anaesthesia should have 
protocols on: 
 "checking equipment and drugs 
 preoperative assessment and preparation 
 syringe labelling 
 difficult/failed intubation 
 malignant hyperpyrexia 
 anaphylaxis 
 local anaesthetic toxicity 
 massive haemorrhage 
 infection control and  
 post-operative care including pain relief."  
 
Espin et al (29) suggest that the operating theatre is one area where there is a 
pressing need for improved safety. This presents a significant challenge and a vital 
first step is to understand the factors that promote unsafe practice in this area. 
2.3 Medication administration errors in anaesthesiology 
The anaesthetic profession requires that multiple, and at times complex preparations 
of drugs be administered at any one time (14). Medication errors in anaesthetics can 
be expected, especially when one keeps in mind the observation made by Fraind et 
al (32) that drug preparation prior to administration may at times require that up to 40 
separate manoeuvres be carried out. This means that there are up to 40 points at 
which an error can occur.  
Morgan refers to ASA Closed Claims Project which found that as many as 4% of the 
malpractice cases in anaesthesia were due to errors of drug administration. This is 
largely related to administration of incorrect doses or what is known as “syringe 
swap”, where an incorrect drug is administered (15).  
Brown-Brumfiels et al (33) noted that in the perioperative period, medication errors 
posed a potentially serious threat to patients‟ well being. They concluded that the 
10 
 
practice of safe medication dispensing and labelling needed to be constant across 
the perioperative spectrum.  
Llewellyn et al (5) suggested that patient safety should be part of the undergraduate 
curriculum at medical school. They also noted that the possibility and prevention of 
medication errors should be constantly emphasised throughout doctors‟ training, at 
internship and registrar level, so that some level of patient safety is constantly 
ensured.  
2.4 Drug error coding system 
In 2005 Abeyskekera et al (11) developed a comprehensive medication 
administration error coding system when reviewing reports from the Australian 
Incident Monitoring Study Database with regard to drug errors in anaesthetic 
practice. The coding system that provides a common language to describe drug 
errors is as follows: 
 “Drug error: a failure to give the drug or dose of drug that was intended. 
 Pre-error: an incident that may have led to drug error, but in which no drug 
was given.  
 Syringe swap: this occurred when a drug was given from a correctly labelled 
syringe but the drug was not the intended one.  
 Equipment error: occurred when equipment malfunction or misuse caused 
an error in drug delivery. 
 Communication error: occurred when the narrative suggested a 
miscommunication between the anaesthetic and or recovery staff or surgeon 
to be the primary cause of a failure to give the drug that was intended. 
 Wrong drug ampoule labelling error: occurred when the contents of the 
syringe were different from that indicated on the label or from what was 
expected to be in the drug ampoule used. This occurred when the drug was 
being prepared either due to the drug being drawn up from an incorrect 
ampoule or mislabelling of the syringe once it was drawn up. 
 Pharmaceutical preparation error: this is defined as a dilution error or when 
the concentration of the intended drug was incorrect, also included were 
errors where there was no drug in the syringe due to failure to draw up or mix 
a drug with diluents. " (11) 
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One other coding system quoted in the literature classifies errors into; omission, 
incorrect dose, substitution, repletion, insertion, incorrect route and other (which 
includes, too rapid administration, wrong interval and sequence errors). However this 
coding was not defined comprehensively.(14, 34) 
2.5 Syringe labelling practice 
Paparella(23) quotes two incidents where unlabelled syringes resulted in erroneous 
drug administration. The first case was where an 11 year old patient was given large 
doses (15 mg) of midazolam, mixed with acetaminophen liquid, intended for oral 
administration into the intravenous line. This occurred after the nurse was called 
away momentarily and upon her return she arrived at the bedside with two 
unlabelled syringes and injected the medication. The patient lost consciousness for 
an extended period of time but he subsequently recovered fully. Another case was 
where an infant was injected with massive doses of an antibiotic which was meant 
for the oral route. The child had a respiratory arrest and fortunately resuscitation was 
successful. These incidents highlight the need for good and consistent labelling 
practices. 
There has been a number of studies done internationally and in South Africa 
highlighting the occurrence of drug errors in anaesthetic practice. A few international 
and South African studies are discussed below.  
2.5.1 International studies 
A study was conducted in 2001 at two hospitals in New Zealand, where 
anaesthetists were requested to anonymously complete a survey. This revealed that 
drug errors and pre-errors were mostly reported by more senior anaesthetists with 
an average experience of greater than 10 years. The most common errors were the 
administration of incorrect doses and incorrect drug, one of the causes being 
incorrect labelling of syringes by the anaesthetist. In the majority of the cases the 
most reported adverse events were, awareness, prolonged action of muscle 
relaxants leading to unplanned post operative ventilation and prolonged 
unconsciousness. (14) 
In the above mentioned study it was extrapolated that an average of approximately 
one error per 133 anaesthetics given occurred and this led to a conclusion that one 
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anaesthetist is likely to make approximately seven errors per year. Meticulous 
syringe labelling could significantly contribute to reducing this number. (14) 
Medication errors affect all healthcare workers that prescribe, prepare or administer 
medication. An online survey on challenges of labelling syringes conducted by the 
American Nurses Association in 2007 reported that 97% of nurses worry about 
medication errors and that 68% were of the opinion that these errors can be reduced 
with consistent syringe labelling. Only 37% of the nurses reported always labelling 
their syringes. (35) 
A review of 896 reports from the Australian Incident Monitoring Study Database (11) 
conducted in 2009, revealed that the incident of drug errors and pre-errors 
associated with syringe or drug preparation error was as high as 50%. Syringe swap 
accounted for 37% of these errors and 25% of the syringe swaps, were due to drug 
labelling errors. The list of drugs in syringe swaps often includes opioids, 
neuromuscular blocking agents, reversal agents, benzodiazepines, vasopressors 
and local anaesthetics. The therapeutic indexes of these drugs vary greatly and 
potential consequence from errors resulting in their substitution could range from 
minor to fatal. In the study minor morbidity was reported in 11.7% of cases, major 
morbidity in 4.4% and death in 0.3%. Mortality is rarely reported as a result of a 
medication error. This is because often the outcome of anaesthesia and surgery can 
be attributed to multiple factors and there may be under reporting of drug errors, 
especially when the anaesthetist remains oblivious of this error. (11) 
In 2010, Brown-Brumfield et al (33) conducted a study aimed at quality improvement 
in the operating theatre at the Cleveland Clinic in Ohio. The aim of this study was to 
assess the staff adherence to a revised medication and solution labelling protocol. 
This protocol was implemented with recommendations from the Joint Commission 
and Association of Peri-Operative Registered Nurses. There were 45 
recommendations including that; all medication be labelled to accommodate the 
needs of the anaesthetic care provider and that all medication should be labelled in 
accordance with generally accepted safety standards. Once the new protocol was 
announced, staff members at the Cleveland Clinic received educational training in its 
implementation. This was followed by a study to assess adherence asking the 
following questions. 
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 " Would staff members dispense and label medication and solutions according 
to the protocol? 
 Would adherence to the protocol differ amongst the various surgical 
specialties? 
 Would adherence to the protocol differ by years of staff member experience? " 
(33) 
It was reported that medical personnel labelled medication 70% of the time and 
checked medication in 60% of the observed cases. The study revealed that non-
adherence to standard labelling protocols was still a problem. Staff members with 
more than 20 years‟ experience had a 40% non-compliance rate with the labelling of 
medication as opposed to 27% in their less experienced colleagues. It was also 
noted that the rate of adherence to prescribed protocols differed amongst different 
medical specialities. Although this was not quantified, it highlighted the need for 
standardisation of medication labelling practice. (33) 
In 2011, a study was conducted at the Carolina Medical Centre Mercy in the USA 
with the aim to ascertain whether the provision of pre-printed medication labels 
would improve compliance with the labelling protocols introduced. The study 
reported that the availability of pre-printed labels improved compliance up to 96% as 
opposed to the control group which only had 26% compliance. The control group 
was supplied with blank labels. (26) 
Much of the reviewed literature has supported the introduction of one 
internationalised method of colour coding and labelling of syringes.(6, 21, 28, 34, 36, 
37) Haslam et al (21) raised concerns of a possible period of increased errors during 
the transition to the international colour coding syringe labelling system. A small 
study was performed where two groups of anaesthetists were asked to use the new 
ISO colour coded labels. The first group had no prior experience with the use of the 
new labels and the second group had used the labels before. In the first group 15% 
pre-errors were reported and 0.9% errors were made. The second group reported 
only 3% pre-errors and no errors occurred. 
2.5.2 South Africa 
A survey on medication errors was conducted by Gordon et al (20) in 2004. It was 
electronically distributed to 720 anaesthetists registered with the South African 
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Society of Anaesthesiology (SASA). A total of 133 anaesthetists responded and of 
these, 125 (94%) admitted to having administered the wrong drug. Only 28 of 125 
anaesthetists reported the errors. Out of the errors reviewed as many as 50% 
involved muscle relaxants and 14% involved vasoactive drugs. The main causes of 
errors were reported to be syringe swap in 40% of the cases, misidentification of the 
drugs in 27.1%, fatigue was responsible in 14.1% and 4.7% were mislabelled 
syringes. In this survey 62% of the anaesthetists were aware of the existence of the 
South African standard colour coding of syringe labels in theatre and only 19% of the 
participants reported using syringe labels as per the national standard. The result of 
the errors was five fatalities, three non-cardiac arrests and in 9.9% of the cases this 
resulted in prolonged anaesthetic time. (20)There was a small sample realisation, 
which may likely have led to an underreported sample. 
A study(22) done in South African academic hospitals between April 2005 and 
January 2006, revealed results similar to the Australian studies mentioned above 
(11, 14). It was found that errors were more likely to be reported by more senior 
anaesthetists and that more than half the errors (54%) were those of drug 
substitution. It was reported that about 21.3% of the drug substitution errors were 
related to syringe identification and that an average of one medication error occurred 
per week. It was suggested in this study that hospitals need to adopt a uniform, 
international, colour coded syringe labelling system as clear labelling of all syringes 
was vital in the efforts to decrease the incident of  medication errors. (22) 
In another survey conducted in 2011 amongst 188 doctors in 22 public sector 
hospitals in the Free State it was revealed that only 23% of the respondents 
indicated that they were aware of a South African Standard for colour coded syringe 
labels and of these only 25% used them regularly. In this survey 80% of registrars 
reported having made administration errors and 93.8% of the consultants reported 
the same. Only 16.7% of the interns reported drug errors, although they 
administered anaesthetic drugs most often in these hospitals. (8) 
2.6 Guidelines for syringe labels 
The Helsinki Declaration on Patient Safety in Anaesthesiology requires that all 
institution administering anaesthesia have protocols on syringe labelling (7) . Various 
countries and institutions have drafted guidelines to be followed by anaesthetists. 
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2.6.1 First registered colour coded labels in the world 
The first colour coded syringe labels in the world were registered in South Africa in 
1985 (SABS 0207-1985), after Professor Pat Foster from Tygerberg hospital, with 
the support of SASA in partnership with SABS, pioneered the development of 
national standard colourcoded syringe labels for anaesthetic drugs. This colour 
coding system has been revised and adopted by various other countries such as 
Australia, Canada and the United Kingdom (UK). The ISO in partnership with SABS 
on the advice of SASA developed the international standards, ISO 26825:2008. (38) 
Details of the ISO 2685 and some of the adopted and revised guidelines will be 
discussed later in the document. 
2.6.2 Australian and New Zealand College of Anaesthesia Guidelines (AS/NZS 
4375:1996) 
The Australian and New Zealand College of Anaesthesia adopted the colour coding 
guidelines and revised them to include more information about the drug. The 
Australia and New Zealand Guidelines for the Safe Administration of Injectable 
Drugs in Anaesthesia, were first published by the Australian and New Zealand 
College of Anaesthetists in 1996. (16) These labelling recommendations put a focus 
on enhancing patient safety. They stipulate which containers should be labelled, e.g. 
bags and bottles for infusion were injectable medicines were added and jugs and 
basins in theatre settings. They also outlined what is to be included on the label and 
where the label should be placed. The information on the syringe labels include: 
 “  patient name (given and family name) 
 patient identifier 
 date of birth 
 active ingredients 
 amount of medicine/s added (including units) 
 volumes of fluid in the syringe in ml 
 concentration (units/ml) 
 diluents 
 date and time prepared 
 prepared by (signature) 
 checked by (signature) and 
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 route of administration (where not specified by wording and colour)” . (16) 
The Australian and New Zealand Guidelines suggest colour coding labels by the 
route of administration e.g. intrathecal, intravenous, oral etc, as opposed to ISO 
standard which colour code labels according to medication class e.g. opioids, muscle 
relaxants etc. 
2.6.3 USA Guideline 
The USA Guidelines (ASTM D4774) were published by ASA in 2004 and are based 
on reports published by the American Society of Testing and Materials and the ISO 
standards. These guidelines are technical and focus mainly on the quality of the 
labels as opposed to the information written on them. They do, however, have a 
place for the dose, date, time and initials of the person that prepared the drugs (see 
Figure 4). The standard focuses on size, colour, pattern and font faceused on labels 
applied to unlabelled syringes filled by the users to identify the drug content. A 
disclaimer attached to the standard states that the standard does not address safety 
concerns in their entirety and if any concerns are associated with its use the 
responsibility lies with the user(39). 
2.6.4 ISO 26825:2008 Standard 
ISO is the world‟s largest developer of voluntary international standards. It has 
approximately 160 member countries and 3368 technical bodies that develop 
standards. The international standards produced by ISO provide gold standard 
specifications for products, services and good practice to various industries, ensuring 
their efficacy. Once a standard is developed, it requires approval by at least 75% of 
the member bodies. (13) 
The general properties of the label to meet the ISO 26825:2008 (24)standard are 
listed below. 
 The label needs to be self-adhesive and not be easily peeled off even after 12 
hours on polyethylene syringes, (material with poor adhesion properties), 
immersion in 50% solution of isopropanolol and water for five minutes. 
 The labels must be easily separable from each other, whether in a tape or 
backing material. 
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 The material of the label should be suitable for the user to write additional 
information on it with a ball-point pen without smudging or blurring. 
 The label packaging should be marked with the number and date of the 
standard, in this case ISO 26825:2008. 
The standard also dictates background colours and designs, examples of which can 
be seen in Figure 2.1. The size of the label should be between 25 to40 mm in length 
and 10 to 15 mm in width. It is dictated as such so as to fit most syringes without 
covering the graduation marks. (24). 
 
Figure 2.1 ISO colour coded pre printed labels (24) 
South Africa has adopted the ISO 26825:2008 guidelines which were implemented 
by the SABS in 2009 (SANS 26825:2009), replacing the 1985 standards. The 
standard focuses on technical aspects of the labels. This covers only the colour, 
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size, design and general properties of the label and the typographical characteristics 
of the wording for the drug name. The standard does not require as much detail as 
that stipulated in the Australian and New Zealand guideline (AS/NZS 4375:1996). 
(24) 
2.6.5 Institute for Safe Medication Practice (ISMP) 
The ISMP which was established with the sole purpose of ensuring patient safety, 
also recognised that labelling of syringes was poorly done and that a standard for 
syringe labelling was required in all hospital departments. Their 2004 survey 
revealed that out of 1600 hospitals in the USA only 41% always labelled medication 
containers and solutions in operating rooms. According to the survey, 18% of 
hospitals did not have labels on their containers and another 42% applied labels 
inconsistently. (30). In 2010, the ISMP offered their recommendations as one of the 
approaches to the prevention of medication errors related to label misinterpretation. 
Figure 2.2 shows an example of the information the ISMP recommends be included 
on the syringe labels. 
 
Figure 2.2 an Example of the label proposed by the ISMP for use in acute 
settings (40) 
2.7 Legal requirements 
In South African courts, negligence is decided on the “reasonable practitioner” 
basis (41). Strauss (41) states that:  
“In order to determine whether or not a person was negligent, the criterion of 
the reasonable man is applied. The question is asked: how would a reasonable 
man have acted in the same circumstances in which the person before the 
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court (the defendant) found himself? The reasonable man is the person of 
average intelligence, knowledge and wisdom. The test is not that of the 
reckless man, but of the person who is aware of possible dangers and who 
takes the necessary precautions to guard against dangers. The (subjective) 
powers of judgement, knowledge and insight of the defendant himself is not the 
determining factor.”(41) 
Legal criteria for negligence is met when it is established that the adverse event 
experienced by the patient was as a result of  the clinician‟s failure to provide 
acceptable standard of medical care (42). This may well be the case in erroneous 
drug administration; as a result, Jansen (25) stated in her thesis that “No medical 
practitioner (or any other health worker) may administer medication without checking 
it properly” (translation from Afrikaans).  
2.8 Legal consequences 
In an era of increasing litigation being brought against physicians, it is important that 
definitions and associated implications of terms often used are well understood. 
Errors, by definition have no blame. Violations on the other hand, are intentional 
deviations from known guidelines and/or protocols designed to maintain safety and 
reflect carelessness and would be judged as such in a court of law. Routinely 
labelling syringes is an internationally accepted important safety measure in all 
medical specialities. Choosing not to adhere to this action may be judged as a 
violation and reasonably considered blameworthy. (3, 16) 
Malpractice complaints, if found in the favour of the patient, may have a variety of 
consequences for the doctor, depending on the complications of the medication 
error. In cases where the doctor is deemed negligent and the patient dies the charge 
of culpable homicide may be brought against the doctor. In some instances a law 
suit may be instituted and in other cases the doctor may be struck off the registration 
board and their practice licence revoked. (43) 
An example of the tragic consequences and heavy penalties that can be incurred 
from drug administration errors, especially when labelling the syringe would have 
prevented the outcome, is the story of Meisha Najeeb. Mesiha Najeeb was a ten- 
year-old in London who received a multimillion pound pay out, after sustaining brain 
damage from having glue accidentally injected in her brain instead of contrast. This 
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error was a result of the two syringes, one with contrast, to make the arteries visible 
and another with the glue to embolise any bleeding vessels, not being labelled and 
hence no way of telling the syringes apart. The judgement in this case ruled that 
Meisha was to receive a £2.8 million lump sum and a £383000 pay out annually until 
she turns 19 and from then on £423000 annually for the rest of her life. According to 
experts she is expected to live well into her 60‟s making this a £24 million pay out, 
the largest ever awarded in the London high court. (17) 
2.9 Management of drug errors 
Drug administration errors are common in all the spheres of medicine that include 
drug administration as a scope of practice. Although there are many guidelines with 
regards to labelling syringes, these are not always adhered to or used. It has been 
shown that a good labelling policy can reduce medication errors in the theatres. (44) 
In Orser et al (6) the anaesthesiology speciality is referred to as the “ODAM” 
profession as unlike other practitioners, anaesthetists order, dispense, administer 
and monitor high risk drugs, all this while performing other tasks in the operating 
theatre. This highlights the complexity of administering anaesthesia and the multiple 
opportunities for drug errors to occur. Standardised colour coded syringe labelling is 
one way of reducing drugs errors. 
Hintong et at (27) in their analysis of the problem of drug errors in anaesthesia in 
Thailand, suggested strategies for the prevention of drug errors. These were 
suggested as they had noted that the introduction of standardised colour coded 
syringe labelling was not necessarily implemented throughout the world and also that 
it was only one way of prevention. Their suggested strategies were as follows 
 All anaesthetists should routinely be careful and attentive in their preparation and 
administration of all drugs. 
 The practitioner should, carefully read every ampoule prior to drawing the drug 
into the syringe. The syringe should be clearly labelled with the drug name and 
concentration and the ampoule is to be checked again prior to being discarded. 
 Care should be taken when reading the label on the syringe and the syringe 
content should always be checked with the person who prepared the drug prior to 
administration. 
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 Every change in the drug formula or packaging should be announced prior to 
being implemented. 
 Use newly prepared drugs and in a case of multi-dosage drug preparations, extra 
care should be taken when reading the label of the drug and the concentration 
and date of preparation should also be noted. (27) 
Prevention of medical errors is a multi-step process and although consistent, 
accurate syringe labelling will go along to prevent many of the errors, it will not 
completely rid the anaesthetic department of the problem. The table used at Royal 
Berkshire Hospital in the UK offers a comprehensive approach to the erroneous drug 
administration frequently seen in theatres. The table is headed “The ten 
commandments for drug usage in theatre”. These are listed below.  
 “Drugs to be stored in generic alphabetical order in the cupboards. 
 No drug to be drawn up in advance of the instruction by the anaesthetist. 
 Extra vigilance to be observed with „emergency drugs‟ 
 All drugs to be labelled at the time of drawing up. 
 Never inject a drug from a non-labelled syringe  
 Never inject a drug that you are not familiar with. 
 Discard all unused, drawn up drugs at the end of the list. 
 Unopened ampoules must not be returned to drug boxes. 
 Keep all empty vials until the patient leaves theatre. 
 Whoever injects a drug is responsible for the drug.” (45) 
In 2005 a large teaching hospital in Ontario, Canada, adopted patient safety as a 
priority. The hospital‟s board of trustees accepted the Accountability for Patient 
Safety Policy. This safety policy created awareness for all staff, volunteers and 
physicians, that ensuring safe health care systems was a shared responsibility. The 
safety policy was adopted after a safety project for operating rooms, under the 
leadership of the Departments of Anaesthesia and Nursing in collaboration with The 
ISMP (Canada), was conducted. The project‟s aim was to recognise areas of risk 
and to make suggestions to improve medication safety in the hospital and also to 
inform development of a medication safety self-assessment specific to the theatre 
environment. A number of findings were made and recommendations tabled. One 
finding was that practitioner prepared solutions, basins and syringes were 
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inconsistently labelled. It was then recommended that all medications and solutions 
up to the point of use be labelled using standardised labelling procedures. (46) 
In 2006 the National Patient Safety Goals, under the directive from The Joint 
Commission(33), USA, instructed health care providers to immediately label all 
medications and medication containers on and off the sterile field in the peri-
operative and other procedural settings. In 2007, extra requirements were added to 
the directive with regards to the detail on the label. The label would include the 
medication‟s name, strength, amount and expiry date. It was also stated that all 
labels attached should be verified by at least two qualified individuals.  
Drug administration errors are common in all medical specialities. Although there are 
many guidelines regarding syringe labelling practices, they are not always adhered 
to or used. It has been shown that a good labelling policy can reduce medication 
errors in theatres. It is also imperative to note that guidelines and protocols have no 
value if there are no means in place to ensure their enforcement. (44) 
2.10 Summary 
Medication errors in anaesthesia are a common occurrence. The number may be 
higher than that quoted in studies as the results are dependent on self-reporting 
surveys and in cases where no adverse event occurred, many practitioners may not 
consider this a notifiable error (24). Much of the reviewed literature has noted that 
syringe labelling is a significant cause of medication errors and an easily preventable 
one with consistent adherence to prescribed guidelines (10, 11, 14, 25, 40). These 
guidelines are numerous and many countries have adopted and revised the ISO 
colour coded syringe labels, which were first pioneered by SABS and SASA (25, 26, 
28, 29). 
Adherence to available guidelines is essential, as it could minimise adverse events 
from drug errors and the complications that may ensue, which may range from minor 
to death (5). The legal implications and consequences may range from fines to 
charges of man slaughter being imposed (30, 31). Although poor syringe labelling 
techniques are flagged as easily preventable, there are a number of causes of 
medication errors ranging from individual to system problems and it is thus important 
to have a multi-factorial approach to prevention strategies (37, 38). 
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This chapter reviewed the literature relevant to the study. The next chapter will 
discuss the methodology of the study. 
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Chapter 3: Research methodology 
3.1 Introduction 
The research methodology was discussed in this chapter under the following 
headings: aim, objectives, ethical considerations, research methodology, validity and 
reliability. 
3.2 Problem statement 
Studies done internationally and nationally have revealed that erroneous drug 
administration was a frequent occurrence in anaesthetic practice (8, 11, 14, 18-22). 
This is not unexpected as the average anaesthetist administers at least a quarter of 
a million drugs in the course of their professional career (22). An important cause of 
medication error that has been highlighted in the literature is that of incorrect syringe 
labelling (3, 11, 16, 18, 20, 22, 23). 
In South Africa, the South African National Standards (SANS 26825:2009) (24) 
based on the ISO standard of 2008, recommends the use of standard colour coded 
labels to mark syringes used in the administration of anaesthetic drugs. This 
standard also includes general properties, such as size, adhesive properties etc, 
which a syringe label should meet. However, it is important to note that additional 
information such as the date, the time and the signature of the health care worker 
who prepared the syringe should also appear on the label. 
Currently, in the operating theatres of the hospitals affiliated to the Department of 
Anaesthesiology at Wits, various medications such as emergency, induction and 
analgesic agents and antibiotics, are prepared in advance by a healthcare worker. 
The researcher's perception is that syringes are not marked in the recommended 
manner. A concern is that the person administering the prepared medication is often 
not the person who prepared it. Jansen (25) stated in her thesis that “No medical 
practitioner (or any other health worker) may administer medication without checking 
it properly” (translation from [Afrikaans]). 
The syringe labelling practices of anaesthetists working in four academic hospitals 
affiliated to Wits are currently unknown.  
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3.3 Aim 
The aim of this study was to audit the syringe labelling practices of anaesthetists in 
four academic hospitals affiliated to Wits. 
3.4 Objectives 
The objectives of this study were to: 
 describe the current method of labelling syringes 
 describe the information recorded on the syringes  
 document the number of items written on each syringe label. 
3.5 Ethical considerations 
Approval to conduct the study was obtained from the Postgraduate Committee of 
Wits (Appendix 1). The Human Research Ethics Committee (medical) of Wits was 
approached for an ethical waiver (Appendix 2) as this was a non-human study. 
Approvals were received from the Medical Advisory Committee of CHBAH (Appendix 
3) and the CEOs of CMAH, HJH and RMMCH (Appendix 4). 
Anonymity of the anaesthetists working in the operating theatres at the time of the 
audit was ensured as their identities were not requested or noted and it is not known 
who drew up the drugs. Confidentiality was maintained as only the researcher and 
supervisors had access to the raw data. Raw data will be stored securely for six 
years following completion of the study. 
The study did not involve the administration of any drug or therapeutic management 
and was conducted in adherence to South African Good Clinical Practice Guidelines 
(47) and the Declaration of Helsinki (48). 
3.6 Research methodology 
3.6.1 Study design 
The research design was prospective, contextual and descriptive. 
A prospective study is one where the researcher collects present time data over a 
course of time. (49) This data was collected from syringes being used in the theatres 
at the time the study was taking place. 
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This study was contextual as it only took place in four academic hospitals affiliated to 
Wits. Context refers the setting for an event(50).  
A descriptive study is one where information is collected in the demarcated study 
field. It aims to describe the variables and, at times, to identify problems with the 
current practice. (49, 51) The researcher did not modify or intervene in the practice in 
the study field. The study described the current syringe labelling practices in the 
operating theatres of the four study hospitals. 
3.6.2 Study population 
The study population was all syringes prepared for anaesthesia during the course of 
a day at the four study hospitals. 
3.6.3 Sample size 
In consultation with a biostatistician and using Epi Info version 6, sample size was 
calculated. Assuming a 35% prevalence of noncompliance to guidelines based on an 
extensive literature review, with a precision of 10% and a 95% confidence interval, 
the minimum number of syringes required was 108. The actual number of syringes 
from each hospital was realised by the number of functional theatres in each hospital 
on the days that the study took place. 
3.6.4 Sampling method 
A consecutive, convenience sampling method was used to collect data. This method 
is inexpensive, accessible and often less time consuming. A convenience sampling 
method is the selection of all the readily available people or objects for the study(51). 
Consecutive sampling is the best choice of non-random sampling as every available 
individual or object within the accessible population is chosen consecutively(52).  
3.6.5 Inclusion and exclusion criteria 
The inclusion criterion was all syringes containing medication, labelled and 
unlabelled, found on the anaesthetic work station. The exclusion criteria were empty 
unlabelled syringes found on the anaesthetic work surfaces and any syringe labelled 
“flush”. 
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3.6.6 Data collection 
The surgical list of patients is often booked the day before surgery and the 
anaesthetist assigned that list has the duty to assess the patients and review the 
results specific to these patients preoperatively. The anaesthetist then formulates an 
anaesthetic plan for the patients. On the morning of the surgery, the practice is for 
the anaesthetist to arrive early and to prepare for the surgical list. This preparation 
includes checking the anaesthetic machine and other equipment and ensuring that 
all drug cupboards are stocked. 
The emergency drugs are often drawn up before the start of the first case as they 
may need to be diluted prior to use. This ensures that no time is wasted in the event 
of an emergency. The number of drugs drawn up pre-emptively varies depending on 
the anaesthetists‟ preferences and the patient profile for the day. The general 
practice is to dilute adrenaline, phenylephrine, atropine and ephedrine in their 
respective syringes and to then label the syringes. Often one drug is diluted in at 
least two syringes, with different concentrations of the same drug in each syringe, for 
e.g. 1 mg ampoule of adrenalin may be diluted into normal saline in a 10 ml syringe 
giving a 100 µg/ml dose, 1 ml of this is then diluted into a 20 ml syringe giving a 
concentration of 5 µg/ml. 
The induction of anaesthesia requires that multiple drugs be administered at any one 
time. These drugs are prepared beforehand and include short acting opioids, 
induction agent and a muscle relaxant at minimum. Antibiotics, analgesics and other 
drugs are frequently necessary depending on the patient profile and type of surgery 
being performed. 
These syringes are often prepared and labelled with a permanent marker by any one 
member of the anaesthetic team which includes a consultant, registrar, medical 
officer and /or intern. Therefore the medication may not be administered by the 
person who prepared it.  
All the syringes on all the anaesthetic surfaces in all the functioning theatres in the 
four academic hospitals were evaluated. Data was collected from the four academic 
hospitals on two consecutive days. CHBAH was sampled on the first day in the 
morning; some of the theatres were sampled before the start of the list and others 
were sampled after the list had commenced. CMJAH was sampled on the morning of 
28 
 
the second day and again different theatres were sampled at various stages of the 
lists. HJH and RMMCH were sampled in the late morning to early afternoon of the 
second day, and at both hospitals sampling was done after the lists had started and 
at various stages of individual cases. All running theatres, including emergency 
theatres were sampled. This was to ensure that the routine syringe labelling of 
anaesthetists was not influenced by the study (the Hawthorne effect). Each theatre 
was only included once to ensure that no anaesthetists were included more than 
once. 
The predetermined standard against which the syringe labelling was compared, was 
drawn up following an extensive literature review. The predetermined standard is 
reflected in the data collection sheet (Appendix 5). 
The following data was collected on a data collection sheet: 
 label present 
 colour-coded label 
 name of medication 
 name of medication abbreviated 
 dose/concentration of medication 
 date medication prepared 
  time medication prepared 
 signature of person preparing medication 
 signature of person checking medication. 
3.6.7 Data Analysis 
Data was entered on a Microsoft Excel® spread sheet and analysed. Frequencies 
and percentages were reported. 
3.7 Validity and reliability of the study 
Validity of a study is an indication of how accurately the measurement represents the 
true value. It is a representation of the appropriateness of the study design and the 
means used to interpret the results. Reliability of a study represents consistency of 
the measure achieved.(53) 
Validity and reliability of this study were ensured by:  
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 using a suitable study design  
 having a representative study sample 
 collecting data on two consecutive days ensured that routine practice was not 
changed 
 researcher being the sole data collector 
 using a validated, predetermined standard against which to compare the 
current labelling practice. 
3.8 Summary 
This chapter discussed the research methodology used for this study. In the 
following chapter research results will be presented and discussed. 
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Chapter 4: Results and discussion 
4.1 Introduction 
In this chapter the results of the study according to the objectives 
as well as a discussion of the results are presented. 
The objectives of this study were to: 
  describe the current method of labelling syringes 
 describe the information recorded on the syringes  
 document the number of items written on each syringe label. 
4.2 Sample realisation 
The minimum number of syringes required for this audit was 108. A total of 279 
syringes were included from theatres at CHBAH, CMJAH, HJH and RMMCH on 
27and 28 January 2015. Of the 279 syringes 122 (44%) were from CHBAH, 84 
(30%) from CMJAH, 56 (20%) from HJH and 17 (6%) from RMMCH. The actual 
number of syringes from each hospital was determined by the number of functional 
theatres in each hospital on the day of data collection.  The number and percentage 
of syringes collected at each hospital are shown in Figure 4.1 
 
Figure 4.1 Number of syringes audited per hospital 
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4.3 Results 
The findings are described using descriptive statistics. The percentage values are 
rounded off to whole numbers. 
4.3.1 Objective: describe the current method of labelling syringes 
Of the 279 syringes included in the audit, 242 (87%) had a label, either stuck on or 
written directly onto the syringe with a permanent marker pen. Of the labelled 
syringes six (2%) were colour coded; these were either in a form of different coloured 
permanent marker pens or coloured labels. Thirty seven (13%) syringes containing 
solutions had no label at all. 
4.3.2 Objective: describe the information recorded on the syringes 
The audit assessed whether the labels included any of the parameters from the 
predetermined standard as described under data collection in Chapter 3. Of the 
labelled syringes, 242 (100%) had the medicine name and of these 92 (38%) had the 
name of the medication abbreviated, 209 (86%) had the drug dose or concentration, 
6(2%) had time, 15(6%) had date, 5(2%) had both time and date, 6(2%) had the 
signature of the person who prepared the drug and1 (0.4%) of the 242 syringes had 
the signature of the person that checked the solution. This information is shown in 
Figure 4.2 
 
Figure 4.2 Labelling information recorded on syringes 
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The breakdown of labelling information per hospital is shown in Figure 4.3. Only one 
syringe had the signature of a person who checked it, therefore this variable is 
omitted from the graph. 
 
 
Figure 4.3 Break down of labelling information per hospital 
4.3.3 Objective: document the number of items written on each syringe label 
 Six items were identified from the literature as essential when labelling syringes. 
The number of items written on the syringes audited for this study is shown in Table 
4.1. None of the syringes complied fully with the predetermined standard. 
Table 4.1 Number of items on the syringe label 
Number of Items 
on syringes 
Number of syringes Percentage 
0 37 13% 
1 33 12% 
2 193 69% 
3 6 2% 
4 8 3% 
5 2 1% 
6 0 0% 
Medicine name
Dose/concentr
ation present
Date Time Signature
CHBAH 87,7% 73,8% 6,6% 2,5% 2,5%
CMJAH 90,5% 81,0% 3,6% 1,2% 3,6%
HJH 80,4% 67,9% 5,4% 3,6% 0,0%
RMMCH 82,4% 76,5% 5,9% 0,0% 0,0%
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4.4 Discussion 
Syringe labelling, although not the only factor, has been identified as one of the 
correctable system factors that can reliably reduce drug errors in the operating 
theatre(3, 11, 16, 18, 20, 22, 23). 
Out of 279 syringes audited from theatres at the four academic hospitals affiliated to 
Wits, 242 (87%) syringes were labelled. These finding were better than those 
reported by Brown-Brumfield et al (33) in 2010 when answering the objective “ would 
staff members dispose and label medication according to protocol?”. In their study 
only 70% of syringes had some form of label and a total of 30% were not labelled at 
all. (33) This is particularly disturbing as the literature suggests that routinely 
labelling syringes is an internationally accepted important safety measure in all 
medical specialities. Not adhering to routine syringe labelling will be deemed a 
violation that may result in litigation and consequently severe penalties where 
negligence is clearly proven. (3, 16)The findings in our study are also better than 
Jenning and Foster (54) reported as only 59% of the syringes in their study were 
labelled. although the numbers in our study are larger than those in similar studies, 
lack of labels on syringes and other medication containers is a very serious omission 
associated with significant  morbidity and at times mortality(2, 13, 17, 40, 48). 
According to Merry et al (16), unlabelled syringes containing any solutions intended 
for a patient should be considered unsafe and should never be used. They referred 
to a case where the anaesthetist administered dopamine to a patient instead of 
magnesium sulphate. The authors reported this error as a result of similarity in the 
two ampoules. In this case, it is suggested that syringe labelling would have provided 
an additional safety step where the name and dose of the drug would have been 
double-checked against the ampoule. 
The labels used on syringes varied in our study. Some syringes had labelling with a 
permanent marker pen, whereas others had a blank label which was written on with 
a pen and some had ampoule stickers pasted on the syringe. In our study only six 
(2%) of syringe labels had some sort of colour coding. The variation of labelling 
formats shows a lack of standardisation with syringe labelling methods by 
anaesthetists in the study hospitals. Brown-Brumfield et al (33) highlight the need for 
standardisation of labels attached to medication or fluid intended for injection into a 
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patient. They discussed a case where a patient died after glutaryldehyde was 
injected into the patient's spinal space after the container was mistaken for that 
containing spinal fluid. This mistake was made even although the anaesthetist had 
labelled the container with spinal fluid “SF” and no label was on the other container. 
(33) Colour coding has not been fully identified as an important tool in reducing the 
number of medication errors, however it has been suggested that it may change the 
nature of medication errors. It has been suggested that colour coding may help 
reduce drug errors between different classes of drugs and could reduce the severity 
of resulting morbidity from the errors. (14, 16, 22, 36, 55) Colour coding has also 
been identified to be especially helpful in cases where syringes are viewed from an 
angle or in stressful situations such as emergency surgery in unstable patients (56). 
In South Africa colour coded syringe labels are available. The study by Labuschage 
et al (8) revealed that only 23% of anaesthetists in the public hospitals in the Free 
State were aware of this fact. 
Standardisation of syringe labelling is an initiative that can be implemented in 
theatres as international and local standards for syringe labels are already in place 
and these only need to be adopted to come into effect. Some examples of these 
labelling standards include the international standard, ISO 26825, (24) which the 
SABS has adopted into their standards and the Australian and New Zealand 
standard adopted from the ISO (AS/NZS 4375:1996). (13, 16) Christie et al (36) 
state that standardisation is an essential component in the design of a safe system 
and that standard colour coded syringe labels are an example of a system based 
approach to syringe labelling. 
Information audited in our study included: presence of a label, whether the label was 
colour coded or not, name of medication, dose and/or concentration of the drug, date 
and time, signature of the person who prepared the drug and the signature of the 
person that checked the drug. These parameters were chosen after an extensive 
literature review and by reviewing different standards for labelling worldwide. The 
ISO 26825 (24) labelling standard highlights colour coding, name of drug and 
dosage as its main content. The Australian and New Zealand Colleges of 
Anaesthetists guidelines published in 2009 required that patient name, hospital 
identification, active ingredients, amounts of medication, volume of fluid, 
concentration, diluents, date and time prepared, signature of the person that 
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prepared the drug and the person that checked the drug be on the label. (16) The 
ASTM D4774-11el requires that the label be colour coded and information to be 
recorded include: name of drug, dose, date, time, and initials of the person that drew 
up the drug (39). 
 In our study 100% of the labelled syringes contained the name of the solution and 
86% of these had the concentration or dose of drug on the label. Merry et al (16) 
state that these are the two most essential items on the syringe label. Out of the 242 
labelled syringes only one (0.4%) had the signature of the person who checked the 
medication, but whether this can be extrapolated into concluding that only one 
syringe was checked by a second person is not certain. Jensen et al (12) emphasise 
the importance of having a second person double-check medication labels before 
drawing up the drug or before administering the drug to the patient. In their research 
they found that having a second person check the drug label would have prevented 
58% of errors.  
A graphical breakdown of results according to hospitals, although not statistically 
analysed, did not show much variation in results between the different hospitals. 
Hospitals sampled on second day did not have better labelling practices than those 
on the first day. It was also noted that the hospitals sampled later in the day did not 
necessarily perform worse than those sampled earlier in the day, suggesting that the 
labelling practices were not influenced by fatigue. The syringes are often prepared 
by registrars who rotate amongst the hospitals and their practice is not expected to 
change depending on their location. 
Another objective of our study was to describe the number of items written on 
syringes compared to those on the predetermined standard. This standard was 
drawn up by the researcher after extensive literature review and from existing 
labelling standards. There were a total of six items audited namely: name of the 
drug, dose or concentration of the drug, date and time, signature of the person who 
prepared the drug and signature of person who checked the drug. None of the 
syringes had all six. The majority of the syringes, 193 (69%) had two items, but not 
necessarily the same two items were recorded on these syringes. Radharishna (55), 
reports on the lack of standardisation both between and within the 35 hospitals he 
surveyed on type of syringe labelling techniques and reports that the great variation 
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and lack of standard protocols was a serious threat to patient safety and called it “ an 
accident waiting to happen” . This variation, although not quantified in our study, was 
also observed, as syringe labelling techniques included labelling with a permanent 
marker pen, a blank label which was written on with a pen and ampoule stickers 
pasted on the syringe. Thirteen percent of syringes had no label at all. 
The Helsinki Declaration on Patient Safety in Anaesthesiology (7) states that one of 
the protocols that should be drawn up in any anaesthetic department is one for 
syringe labelling. They emphasise that this fact is as important as factors such as 
difficult intubation and massive haemorrhage, and that it is a significant cause of 
morbidity and mortality. 
Although medication error is regarded as mostly a system error, the “person” actually 
still prevails and the law has the tendency to hold the last person holding the 
“smoking gun” accountable. Although this was a small study, it is a significant one as 
it highlights one system error that will see the practitioner being held liable for the 
outcome.(25) 
 
4.5 Summary 
In this chapter, results of the study were presented and discussed. The next chapter 
contains a study summary, the limitations, recommendations and a conclusion of the 
study. 
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Chapter 5: Summary, limitations, 
recommendations and conclusion 
5.1 Introduction 
In this final chapter a summary of the study, the limitations of the study, 
recommendations and the conclusion of the study are presented. 
5.2 Study summary 
5.2.1 The aim of the study 
The aim of this study was to audit the syringe labelling practices of anaesthetists in 
four academic hospitals affiliated to Wits.  
5.2.2 The objectives of the study 
The objectives of this study were to: 
 describe the current method of labelling syringes 
 describe the information recorded on the syringes  
 document the number of items written on each syringe label. 
5.2.3 Summary of the study methodology 
The research design of this study was prospective, contextual and descriptive. It 
described the syringe labelling practices of anaesthetists in the four academic 
hospitals affiliated to Wits, namely CHBAH, CMJAH, HJH and RMMCH. A 
consecutive, convenience sampling method was used to collect data. 
The study population was all the syringes prepared for anaesthesia during the 
course of the data collection day at the study hospitals. Included in the study were 
labelled and unlabelled syringes containing medication found on anaesthetic work 
surfaces. Empty unlabelled syringes found on anaesthetic work surfaces and any 
syringes labelled “flush” were excluded from the study. 
Data was collected by the researcher on two consecutive days. The syringes in each 
theatre were only audited once to ensure that no anaesthetist was included more 
than once. The syringes were audited against predetermined standards. 
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5.2.4 Summary of results 
A total of 279 syringes were included in the study. Of the 279 syringes 242 (87%) 
were labelled. Six (2%) of the 242 labels were colour coded. A total of 37 (13%) 
syringes had no labelling at all. 
All labelled syringes had the name of the medication present, either in full or 
abbreviated. Two hundred and nine(86%) of the labelled syringes had the dose 
and/or concentration of the medication. Fifteen (6%) of syringes had date, 6(2%) had 
time and 5(2%) had both time and date written on them. A total of six(2%) syringes 
had the signature of the person who prepared the drug and only one (0.4%) of the 
242 labelled syringed had the signature of the person that checked the drug. The 
majority 193 (69%) of syringes had only two out of the six required labelling items. 
5.3 Limitations of the study 
The limitations of the study included the following: 
 The study is contextual and the results of the study may not be generalisable 
to other hospitals.  
 It was also a “snapshot” of practice during weekday normal working hours and 
does not reflect practice over 24 hours and especially during calls.  
 As data collection was done over two days, there was a possibility that 
anaesthetists in the hospitals sampled on the second day may have heard of 
the study and had an opportunity to change their practice. This is known as 
the Hawthorne effect. In our study there did not appear to be any change of 
practice on the second day.  
 
5.4 Recommendations for the study 
5.4.1 Recommendation for clinical practice 
Recommendations for clinical practice. 
 Feedback of the results of the study be communicated to the anaesthesiology 
department and educational lectures be conducted. 
 Syringe labelling standing operating procedure should be developed. 
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 Motivate for the use of pre printed colour coded syringe labels in the study 
hospitals. 
5.4.2 Recommendations for research 
Recommendation for research. 
 The study should be repeated after the feedback and educational lecture as 
well as the implementation of the standard operating procedure. 
 A study to understand the possible systems problems that contribute to 
incorrect labelling practices. 
 A study comparing labelling practices in emergency drugs vs. non- 
emergency drugs and also looking at labelling practices in emergency cases 
vs. elective cases. 
 As the literature has shown a correlation between anaesthetist level of 
experience and labelling practice, a study could be done to address this issue. 
5.5 Conclusion 
This study revealed that syringe labelling practices of anaesthetists in the four 
academic hospitals associated with Wits did not meet the recommended standards. 
It is recommended that a standard operating procedure for syringe labelling be 
introduced as studies have shown that syringe labelling is an easy way of preventing 
and/or reducing medication error. 
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Appendix 5: Data collection sheet 
 
Study Number 
Present Yes No 
Label present   
Colour-coded label   
Name of 
medication 
  
Name of 
medication 
abbreviated 
  
Dose/concentration 
of medication 
  
Date medication 
prepared 
  
Time medication 
prepared 
  
Signature of person 
preparing medication 
 
  
Signature of person 
checking medication. 
 
  
 
 
 
